Anne Samuel

Stock Analyst at JP Morgan

(1.36)
# 1632
Out of 5,333 analysts
79
Total ratings
48.72%
Success rate
13.38%
Average return
20 Stocks
Name Action PT Current % Upside Ratings Updated
OMCL Omnicell
Maintains: Neutral
44 36
25.83 39.37% 5 Mar 20, 2025
VEEV Veeva Systems
Maintains: Neutral
218 249
236.78 5.16% 6 Mar 20, 2025
EVH Evolent Health
Maintains: Overweight
13 12
9.09 32.01% 12 Mar 10, 2025
IQV IQVIA Hldgs
Maintains: Overweight
240 232
148.88 55.83% 6 Feb 18, 2025
PGNY Progyny
Maintains: Neutral
17 23
21.2 8.49% 7 Jan 28, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
30 48
59.15 -18.85% 5 Nov 21, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
27 28
25.6 9.38% 2 Sep 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
21 19
23.07 -17.64% 4 Sep 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underweight
19 21
22.46 -6.5% 3 Sep 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
10 13
4.13 214.77% 3 Sep 4, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
24 27
40 -32.5% 2 Aug 19, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underweight
7 5
3.68 35.87% 1 Jul 31, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
86 108
90.43 19.43% 7 Apr 2, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
20 11
n/a n/a 3 Dec 13, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
30 25
n/a n/a 1 Dec 13, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Underweight
19 20
n/a n/a 1 Nov 18, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
32 31
n/a n/a 2 Sep 6, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
12
n/a n/a 1 Jul 12, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Underweight
14 15
n/a n/a 4 Apr 24, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
148 159
n/a n/a 4 Apr 24, 2018